HORIZON PHARMA
Horizon Therapeutics operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include HZT-501, a proprietary fixed-dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine. Horizon Therapeutics is based in Northbrook, Illinois, and was founded in 2005.
HORIZON PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
Northbrook, Illinois, United States
Country:
United States
Website Url:
http://www.horizontherapeutics.com
Total Employee:
501+
Status:
Active
Contact:
+353 1 772 2100
Email Addresses:
[email protected]
Total Funding:
2.26 B USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Amazon Virginia Region Gravity Forms Facebook Domain Verification MailChimp SPF Sendgrid
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Open Innovation Partners
Open Innovation Partners focuses on the development of cancer therapeutic agents.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-05-08 | River Vision Development | River Vision Development acquired by Horizon Pharma | 145 M USD |
2016-09-12 | Raptor Pharmaceuticals | Raptor Pharmaceuticals acquired by Horizon Pharma | 800 M USD |
2015-03-30 | Hyperion Therapeutics | Hyperion Therapeutics acquired by Horizon Pharma | 1.1 B USD |
2014-03-19 | Vidara Therapeutics | Vidara Therapeutics acquired by Horizon Pharma | N/A |
2010-04-01 | Nitec Pharma AG | Nitec Pharma AG acquired by Horizon Pharma | N/A |
Investors List
Cowen and Company
Cowen and Company investment in Post-IPO Debt - Horizon Pharma
Deerfield
Deerfield investment in Post-IPO Debt - Horizon Pharma
Citigroup Global Markets
Citigroup Global Markets investment in Post-IPO Debt - Horizon Pharma
Pequot Capital
Pequot Capital investment in Series C - Horizon Pharma
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Horizon Pharma
Sutter Hill Ventures
Sutter Hill Ventures investment in Series C - Horizon Pharma
Sutter Hill Ventures
Sutter Hill Ventures investment in Series B - Horizon Pharma
Pequot Capital
Pequot Capital investment in Series B - Horizon Pharma
Scale Venture Partners
Scale Venture Partners investment in Series B - Horizon Pharma
Official Site Inspections
http://www.horizontherapeutics.com
- Host name: ec2-3-219-78-25.compute-1.amazonaws.com
- IP address: 3.219.78.25
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149